Safi R. Bahcall

2013

In 2013, Safi R. Bahcall earned a total compensation of $2.3M as Former President and Chief Executive Officer at Synta Pharmaceuticals, a 13% increase compared to previous year.

Compensation breakdown

Option Awards$1,780,361
Salary$516,667
Other$31,888
Total$2,328,916

Bahcall received $1.8M in option awards, accounting for 76% of the total pay in 2013.

Bahcall also received $516.7K in salary and $31.9K in other compensation.

Rankings

In 2013, Safi R. Bahcall's compensation ranked 3,362nd out of 12,286 executives tracked by ExecPay. In other words, Bahcall earned more than 72.6% of executives.

ClassificationRankingPercentile
All
3,362
out of 12,286
73rd
Division
Manufacturing
1,136
out of 4,612
75th
Major group
Chemicals And Allied Products
302
out of 1,466
79th
Industry group
Drugs
206
out of 1,160
82nd
Industry
Pharmaceutical Preparations
170
out of 890
81st
Source: SEC filing on April 30, 2014.

Bahcall's colleagues

We found five more compensation records of executives who worked with Safi R. Bahcall at Synta Pharmaceuticals in 2013.

2013

Sumant Ramachandra

Synta Pharmaceuticals

Former President, Research and Development

2013

Vojo Vukovic

Synta Pharmaceuticals

Chief Medical Officer

2013

Amar Singh

Synta Pharmaceuticals

Former Senior Vice President, Chief Business Officer

2013

Keith Ehrlich

Synta Pharmaceuticals

Chief Financial Officer

2013

Steven Bernitz

Synta Pharmaceuticals

Senior Vice President, Chief Business Officer

In-depth

You may also like